"Chemokine CXCL11" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
A CXC chemokine that is induced by GAMMA-INTERFERON. It is a chemotactic factor for activated T-LYMPHOCYTES and has specificity for the CXCR3 RECEPTOR.
Descriptor ID |
D054371
|
MeSH Number(s) |
D12.644.276.374.200.120.550 D12.776.467.374.200.120.550 D23.125.300.120.550 D23.469.200.120.550 D23.529.374.200.120.550
|
Concept/Terms |
Chemokine CXCL11- Chemokine CXCL11
- CXCL11, Chemokine
- Small Inducible Cytokine Subfamily B, Member 11 Protein
- CXC Chemokine, H174
- Chemokine, H174 CXC
- H174 CXC Chemokine
- CXCL11 Chemokine
- Chemokine, CXCL11
- Chemoattractant I-TAC
- Chemoattractant I TAC
- CXC Chemokine I-TAC
- CXC Chemokine I TAC
- Chemokine I-TAC, CXC
|
Below are MeSH descriptors whose meaning is more general than "Chemokine CXCL11".
Below are MeSH descriptors whose meaning is more specific than "Chemokine CXCL11".
This graph shows the total number of publications written about "Chemokine CXCL11" by people in this website by year, and whether "Chemokine CXCL11" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
Year | Major Topic | Minor Topic | Total |
---|
2005 | 0 | 1 | 1 |
2008 | 0 | 1 | 1 |
2017 | 0 | 1 | 1 |
To return to the timeline,
click here.
Below are the most recent publications written about "Chemokine CXCL11" by people in Profiles.
-
Nastase MV, Zeng-Brouwers J, Beckmann J, Tredup C, Christen U, Radeke HH, Wygrecka M, Schaefer L. Biglycan, a novel trigger of Th1 and Th17 cell recruitment into the kidney. Matrix Biol. 2018 08; 68-69:293-317.
-
Voss JG, Raju R, Logun C, Danner RL, Munson PJ, Rangel Z, Dalakas MC. A focused microarray to study human mitochondrial and nuclear gene expression. Biol Res Nurs. 2008 Apr; 9(4):272-9.
-
Golovina TN, Morrison SE, Eisenlohr LC. The impact of misfolding versus targeted degradation on the efficiency of the MHC class I-restricted antigen processing. J Immunol. 2005 Mar 1; 174(5):2763-9.